Medical Communications

Showing 15 posts of 6417 posts found.

Taking science and making people feel connected to it

August 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical, rare diseases

Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …
pills_in_hand

The pendulum swing of generic drug prices

August 18, 2017 Medical Communications biotech, drugs, generics, pharma, pharmaceutical

The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …

Pfizer’s leukaemia drug gets opposing regulatory decisions on either side of the Atlantic

August 18, 2017 Medical Communications, Sales and Marketing Besponsa, Cancer, FDA, NICE, Pfizer, leukaemia, pharma, pharmaceutical

Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval …
astrazeneca_logo_building

AZ and MSD secure three bits of good news on key drug

August 18, 2017 Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical

It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …

Longest-serving chief exec in NHS sacked for ‘gross misconduct’

August 18, 2017 Medical Communications NHS, Newcastle, biotech, drugs, pharma, pharmaceutical

Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he …
heart-2338154_960_720

Where will the next cardiovascular breakthrough come from?

August 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical

British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …

FDA recalls liquid pharma products after bacterial contamination detected

August 17, 2017 Medical Communications, Sales and Marketing FDA, life sciences, pharma, pharmaceutical

The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products …

Takeda strikes partnership to develop single-drug cancer combo immunotherapies

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …
shutterstock_95714119

Over 1,000 currently active cancer trials spell trouble for patient recruitment

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …
energy-bar-snack-chocolate-bar-chocolate-candy-1636220

‘Hugely disturbing’ rise in UK children with type 2 diabetes, report finds

August 14, 2017 Medical Communications, Sales and Marketing childhood obesity, diabetes, healthcare, life sciences, obesity, pharma, pharmaceuticals

A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

FDA investigating intragastric obesity treatment linked to five deaths

August 14, 2017 Medical Communications, Sales and Marketing life sciences, medicine, obesity, pharma, pharmaceutical

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …
celgene_1_02

Celgene opts not to acquire Sutro Biopharma for $1bn, reworks existing partnership

August 11, 2017 Medical Communications, Sales and Marketing Celgene, Sutro Biopharma, biotech, healthcare, life sciences, medicine, pharma, pharmaceutical

Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …
The Gateway to Local Adoption Series

Latest content